WHO:
Join Gibson for a special event with Women Who Rock supporting groundbreaking Breast Cancer and Women’s Health Research.
Women Who Rock will debut a new merchandise line on Wednesday, August 25 live at the Gibson Garage in downtown Nashville. This edgy line is female-founded and designed with a portion of proceeds funding life-saving breast cancer and women’s health research at Magee-Womens Research Institute (MWRI). Items include the signature Women Who Rock lightning bolt pin, a Gibson X Women Who Rock guitar strap and guitar picks, t-shirts, onesies, tanks, and one-of-a-kind handmade jewelry. The new line will be available online via
Women Who Rock following the event.
The Women Who Rock event will feature a special presentation from Melinda Colaizzi, (Founder, Women Who Rock) and Michael Annichine (CEO, Magee-Womens Research Institute), as well as live music at the Gibson Garage.
WHAT:
- Women Who Rock Event -- Nashville (event is open to the public)
WHEN:
- Wednesday, August 25 at 4:00pm
- Arrivals: 3:45pm; Presentation starts: 4:00pm
- Photo Opp + One-on-One Interviews: 4:20pm
- Live music begins 4:30pm
WHERE:
- Gibson Garage--209 10th Avenue South Nashville, TN 37203
RSVP:
WHY:
Women Who Rock connects through the power of music and helps educate, support and fund women-centric health research. The annual Women Who Rock Benefit Concert in October features some of the brightest stars in music today with a 100% female-fronted line-up. All donations to Women Who Rock support the Magee-Womens Research Institute (MWRI)--the nation's largest research institute dedicated solely to life-saving women's health research. Stay tuned for announcement re the October 2021 Women Who Rock Benefit Concert.
October is Breast Cancer Awareness Month and Women’s health overall is underfunded and understudied. While most health research has sidestepped sex differences, Magee-Womens Research Institute (MWRI) is the nation’s largest research institute dedicated solely to women’s health research. In addition, MWRI currently offers 192 studies enrolling 162,000 women in clinical trials all over the world. Researchers at MWRI are working on chemotherapy resistance for the most common form of breast cancer, finding a more effective treatment for triple negative breast cancer, and running more than 20 clinical trials to develop new, personalized treatments for women.
